These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6411085)

  • 1. Myelin proteins: degradation in rat brain initiated by metabolites causative of maple syrup urine disease.
    Tribble D; Shapira R
    Biochem Biophys Res Commun; 1983 Jul; 114(2):440-6. PubMed ID: 6411085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease.
    Tavares RG; Santos CE; Tasca CI; Wajner M; Souza DO; Dutra-Filho CS
    J Neurol Sci; 2000 Dec; 181(1-2):44-9. PubMed ID: 11099711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolongation of G1 and S phase in C-6 glioma cells treated with maple syrup urine disease metabolits. Morphologic and cell cycle studies.
    Liao CL; Herman MM; Bensch KG
    Lab Invest; 1978 Feb; 38(2):122-33. PubMed ID: 564423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular levels and metabolism of leucine and alpha-ketoisocaproate in normal and maple syrup urine disease fibroblasts.
    Wendel U; Langenbeck U
    Biochem Med; 1984 Jun; 31(3):294-302. PubMed ID: 6477534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maple syrup urine disease metabolites studies in cerebellum cultures.
    Silberberg DH
    J Neurochem; 1969 Jul; 16(7):1141-6. PubMed ID: 5816072
    [No Abstract]   [Full Text] [Related]  

  • 7. Synaptic plasma membrane Na(+), K (+)-ATPase activity is significantly reduced by the alpha-keto acids accumulating in maple syrup urine disease in rat cerebral cortex.
    Wajner A; Bürger C; Dutra-Filho CS; Wajner M; de Souza Wyse AT; Wannmacher CM
    Metab Brain Dis; 2007 Mar; 22(1):77-88. PubMed ID: 17295076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease.
    Jouvet P; Rustin P; Taylor DL; Pocock JM; Felderhoff-Mueser U; Mazarakis ND; Sarraf C; Joashi U; Kozma M; Greenwood K; Edwards AD; Mehmet H
    Mol Biol Cell; 2000 May; 11(5):1919-32. PubMed ID: 10793161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts.
    Skaper SD; Molden DP; Seegmiller JE
    Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of abnormal metabolites of maple syrup urine disease on neurotransmitter receptor binding.
    Dwivedi C; James EC; Parmar SS
    Biochem Med Metab Biol; 1986 Jun; 35(3):275-8. PubMed ID: 3013257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maple syrup urine disease: branched-chain keto acid decarboxylation in fibroblasts as measured with amino acids and keto acids.
    Dancis J; Hutzler J; Cox RP
    Am J Hum Genet; 1977 May; 29(3):272-9. PubMed ID: 868873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood and tissue branched-chain amino and alpha-keto acid concentrations: effect of diet, starvation, and disease.
    Hutson SM; Harper AE
    Am J Clin Nutr; 1981 Feb; 34(2):173-83. PubMed ID: 7211722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the branched-chain alpha-keto acids accumulating in maple syrup urine disease induce morphological alterations and death in cultured astrocytes from rat cerebral cortex.
    Funchal C; Gottfried C; De Almeida LM; Wajner M; Pessoa-Pureur R
    Glia; 2004 Nov; 48(3):230-40. PubMed ID: 15390119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of brain energy metabolism by the alpha-keto acids accumulating in maple syrup urine disease.
    Sgaravatti AM; Rosa RB; Schuck PF; Ribeiro CA; Wannmacher CM; Wyse AT; Dutra-Filho CS; Wajner M
    Biochim Biophys Acta; 2003 Nov; 1639(3):232-8. PubMed ID: 14636955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maple syrup urine disease: alpha-ketoisocaproate decarboxylation activity in different types of cultured amniotic fluid cells.
    Wendel U; Gamm G; Claussen U
    Prenat Diagn; 1981 Oct; 1(4):235-40. PubMed ID: 7346826
    [No Abstract]   [Full Text] [Related]  

  • 16. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
    Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease.
    Bridi R; Araldi J; Sgarbi MB; Testa CG; Durigon K; Wajner M; Dutra-Filho CS
    Int J Dev Neurosci; 2003 Oct; 21(6):327-32. PubMed ID: 12927581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic signaling pathways induced by acute administration of branched-chain amino acids in an animal model of maple syrup urine disease.
    Vilela TC; Scaini G; Furlanetto CB; Pasquali MA; Santos JP; Gelain DP; Moreira JC; Schuck PF; Ferreira GC; Streck EL
    Metab Brain Dis; 2017 Feb; 32(1):115-122. PubMed ID: 27510712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of alpha-oxoglutarate and pyruvate oxidation by alpha-oxoderivatives of leucine and valine in rat tissues.
    Lysiak W; Stepiński J; Angielski S
    Acta Biochim Pol; 1970; 17(2):131-41. PubMed ID: 5530500
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein and leucine metabolism in maple syrup urine disease.
    Thompson GN; Bresson JL; Pacy PJ; Bonnefont JP; Walter JH; Leonard JV; Saudubray JM; Halliday D
    Am J Physiol; 1990 Apr; 258(4 Pt 1):E654-60. PubMed ID: 2185648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.